![](https://webarchive.library.unt.edu/eot2008/20090514033440im_/http://www.cancer.gov/images/spacer.gif) |
|
(er-LOH-ty-nib)
![](https://webarchive.library.unt.edu/eot2008/20090514033440im_/http://www.cancer.gov/images/spacer.gif)
| A drug used to treat certain types of non-small cell lung cancer. It is also used together with gemcitabine to treat pancreatic cancer and is being studied in the treatment of other types of cancer. Erlotinib is a type of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. Also called CP-358,774, erlotinib hydrochloride, OSI-774, and Tarceva. |
Previous Definitions: | ErbB1, Erbitux, ERCP, erectile dysfunction, erection | Next Definitions: | erlotinib hydrochloride, ERT, ERUS, erythema, erythrocyte |
|
![](https://webarchive.library.unt.edu/eot2008/20090514033440im_/http://www.cancer.gov/images/spacer.gif) |